CCSD code E3180 – Medialization thyroplasty

Key takeaways

CCSD Code E3180 covers Isshiki type 1 thyroplasty only, not types II, III or IV, which are different operations.

The procedure is typically performed under local anaesthesia so the patient can vocalise during implant placement.

Most UK private insurers typically require pre-authorisation before E3180 is performed, so check each insurer’s current rules before the operation is booked.

Arytenoid adduction is a separate procedure, so check the current CCSD schedule and each insurer’s own rules before billing it alongside E3180.

In Pabau’s practice management software, the operative note, authorisation number and approved codes sit on one patient record before the insurer invoice goes out.

CCSD Code E3180: definition and what it covers

CCSD Code E3180 has the official descriptor “Thyroplasty (Isshiki type 1).” It sits in the ear, nose and throat chapter of the CCSD schedule of procedures. That schedule is the coding standard UK private insurers such as Bupa, AXA Health, Aviva and Vitality use.

The code covers the complete surgical episode: creation of a cartilage window, implant insertion and intraoperative voice assessment. It does not bundle the anaesthetic fee, which the anaesthetist bills separately. Nearby larynx procedures sit alongside it in our index of UK CCSD codes.

Type 1 is the most often performed Isshiki thyroplasty. It is a medialization procedure for glottic insufficiency caused by unilateral vocal fold paralysis. The other Isshiki types are distinct operations for different laryngeal conditions, and each has its own code. Submitting E3180 for a type II, III or IV procedure is a coding error that will trigger a review.

What is an Isshiki type 1 thyroplasty?

Isshiki type 1 thyroplasty is a medialization procedure that permanently repositions a paralysed vocal fold toward the midline. The fold can then meet the mobile fold on the other side during phonation.

The surgeon cuts a small rectangular window in the thyroid cartilage (the thyroid ala) on the affected side. A shaped implant goes through the window to push the vocal fold medially. The surgeon adjusts its position while the patient phonates under local anaesthesia. Once the voice sounds right, the surgeon secures the implant and closes the wound.

Implant materials vary with the surgeon’s choice, and the CCSD descriptor does not specify them. Accepted materials include Gore-Tex, silastic block, silicone and hydroxyapatite prostheses. The choice of material does not change the code, but it should be documented in the operative note for insurer review.

Why local anaesthesia matters for documentation

Most surgeons perform E3180 under local anaesthesia with sedation because it allows intraoperative flexible nasendoscopy and live voice assessment. The patient counts or sustains a vowel sound while the implant position is adjusted.

The operative note should record this assessment: the laryngoscopy findings, the voice improvement achieved and any adjustments made before closure. Insurers reviewing E3180 claims more often look for this record as evidence that the procedure was completed as described.

Indications: when is CCSD Code E3180 performed?

The primary indication for E3180 is unilateral vocal fold paralysis causing symptomatic glottic incompetence. Dysphonia (hoarse or breathy voice) is the most common presenting complaint. Aspiration risk and dysphagia are equally valid surgical indications, especially in patients with a posterior glottic gap.

• Vocal fold paralysis: unilateral paralysis causing incomplete glottic closure, which flexible nasendoscopy or laryngeal videostroboscopy confirms.
• Failed conservative management: voice therapy has not restored voice function after a reasonable trial, typically three to six months from onset.
• Failed or insufficient injection augmentation: temporary vocal fold injection augmentation has not provided enough or lasting benefit.
• Aspiration risk: incomplete glottic closure during swallowing raises the risk of aspiration pneumonia. That makes surgical medialization clinically necessary rather than elective.
• Stable paralysis: the paralysis is unlikely to resolve spontaneously, or the patient cannot wait for the resolution window to close.

Aspiration and dysphagia indications carry more weight with insurers at pre-authorisation because they cross into medical necessity. Clinical documentation should make the indication explicit. Compare a letter noting “dysphonia following thyroid surgery with stable left vocal fold paralysis at eight months” with one listing only “voice disorder.” The first makes a far stronger claim.

Isshiki thyroplasty types compared

The four Isshiki types address different mechanical problems of the laryngeal framework. E3180 describes only type 1. The table below summarises all four so coders can confirm the correct code before submission.

Surgical technique: step-by-step

Knowing the operative steps shows billing staff what the operative note must contain and what a claim reviewer will look for. The sequence below reflects standard practice in laryngeal framework surgery.

1. Patient positioning: the patient lies supine with the neck extended. The surgeon infiltrates local anaesthetic with adrenaline into the anterior neck.
2. Skin incision: the surgeon makes a horizontal cervical incision, usually 3-4 cm, at the level of the thyroid cartilage midpoint.
3. Thyroid cartilage exposure: the surgeon divides the strap muscles in the midline and retracts them to expose the affected thyroid ala.
4. Cartilage window: the surgeon marks and cuts a rectangular window in the thyroid ala. The patient’s sex and cartilage dimensions set its position, and the surgeon preserves the inner perichondrium.
5. Implant sizing and insertion: the surgeon sizes trial implants against the window. The surgeon then shapes the chosen implant (Gore-Tex, silastic or hydroxyapatite) and inserts it to push the paralysed vocal fold medially.
6. Intraoperative laryngoscopy and voice assessment: flexible nasendoscopy confirms fold position while the patient phonates. The surgeon adjusts the implant until glottic closure and voice quality are as good as they can be.
7. Implant fixation and wound closure: the surgeon secures the implant and closes the strap muscles and skin in layers.

Related CCSD codes and how they interact with E3180

Billers often submit several codes alongside or instead of CCSD Code E3180. Knowing how each one relates to E3180 prevents both under-coding and unbundling errors. The Bupa CCSD code schedule is a useful reference for current fee levels and insurer-specific bundling restrictions.

A pre-operative scope done at a separate outpatient visit is its own claim. When the scope is the only procedure that day, it may fall under E3680, the code for endoscopic laryngopharyngoscopy as a sole out-patient procedure.

E3180 vs vocal fold injection augmentation

Vocal fold injection augmentation is a different procedure that uses E3810, the CCSD code for injection into the larynx. A bulking agent (fat, hyaluronic acid or calcium hydroxylapatite) goes into the paralysed fold transorally or transcervically. Surgeons usually do it under general anaesthesia, or under local anaesthesia with sedation.

The key clinical difference is durability. Injection augmentation typically lasts months, whereas surgeons consider medialization thyroplasty long-lasting, and most patients keep the benefit for years. Surgeons often use injection as a temporary measure while awaiting spontaneous recovery. It can also act as a diagnostic test of medialization benefit before committing to surgery.

Do not bill both procedures on the same episode. When injection augmentation was performed earlier and the patient then undergoes E3180, the earlier injection claim is a separate historic episode, not a bundling risk.

E3180 and arytenoid adduction

Surgeons perform arytenoid adduction when the paralysed vocal fold sits at a different height from the mobile fold (level mismatch). They also use it when a posterior glottic gap is too wide for medialization alone to close. A suture repositions the arytenoid to improve posterior glottic contact.

It addresses a different anatomical problem from the implant placed in E3180, so check the current CCSD schedule for how to code it. Whether both procedures can be claimed on the same episode depends on that schedule and each insurer’s own rules. Check both before the operation, and get written pre-authorisation that names every planned procedure.

Documentation requirements for a valid CCSD Code E3180 claim

A valid E3180 claim needs documentation that confirms the surgeon performed the procedure as coded. Insurers often query or reject claims at audit when any item below is missing. The flow below shows which stage produces each record, from pre-authorisation to submission.

• Diagnosis and laterality: the referral letter or pre-admission note must state the diagnosis (e.g. “left unilateral vocal fold paralysis”). The operative note must confirm the side operated on.
• Isshiki type: the note must state “Isshiki type 1” or “medialization thyroplasty” explicitly. “Thyroplasty” alone does not confirm the type for coding purposes.
• Implant material and dimensions: document the implant type (e.g. Gore-Tex), the size or dimensions, and the manufacturer where relevant.
• Cartilage window measurements: surgeons vary in whether they record this, but it helps answer insurer queries on technique.
• Intraoperative laryngoscopy findings: confirm that the surgeon performed flexible nasendoscopy during the operation. Record glottic closure before and after implant placement, and how the patient’s voice sounded at the end.
• Anaesthetic type: record whether the surgeon used local anaesthesia with sedation or general anaesthesia. Local anaesthesia is standard for type 1 because it enables the voice assessment. If general anaesthesia was used, document the clinical reason.
• Pre-authorisation reference number: the insurer’s authorisation number must appear on the invoice. Most insurer systems return claims without it.

Pre-authorisation: what UK private insurers require

Most UK private insurers typically treat CCSD Code E3180 as an elective ENT procedure that needs pre-authorisation. Approval after the event may not be available, so a claim without an authorisation number risks rejection whatever the clinical need. Requirements vary, so check each insurer’s current rules. Most follow a broadly similar pattern.

• Referral pathway: a GP or specialist referral letter naming the indication (vocal fold paralysis, dysphonia, aspiration risk) and the proposed procedure by CCSD code.
• Laryngoscopy evidence: a flexible nasendoscopy or laryngeal videostroboscopy report confirming vocal fold immobility on the affected side. Some insurers limit how old this report can be, so check each insurer’s current rules.
• Conservative treatment record: evidence that the patient tried voice therapy, or a clinical explanation of why it was not appropriate (e.g. severe aspiration risk).
• Proposed co-submitted codes: if the team plans arytenoid adduction or any other concurrent procedure, include every CCSD code in the pre-authorisation request. Some insurers will not add a code after the event.

Each insurer publishes its own fees and criteria. Check Bupa’s code lookup portal or the Aviva procedure fee schedule. For the other two, use the AXA Health procedure codes portal and the Vitality fee finder. Benefit levels can differ even within one insurer’s product range. Check the patient’s specific policy before you submit the authorisation request.

Common reasons E3180 claims are rejected

Denials for CCSD Code E3180 follow a predictable pattern, and you can prevent each reason below before submission.

• Missing pre-authorisation: a frequent reason. Most insurer claim systems return an invoice that carries no authorisation number.
• Wrong Isshiki type: the claim used E3180 for a type II, III or IV procedure, or for what was in fact a vocal fold injection augmentation.
• Laterality absent from operative note: the note says “thyroplasty” but does not state the side. Insurers need laterality to match the procedure to the pre-authorisation.
• Implant not documented: no material or size recorded. Without implant details, reviewers cannot verify the procedure was completed as described.
• Unbundled codes not pre-authorised: arytenoid adduction or another co-procedure billed alongside E3180 although the original authorisation left it out.
• Late claim: insurers set their own submission windows, so check each insurer’s current rules. A late claim can be rejected however complete the documentation is.
• Diagnostic code missing or mismatched: the diagnosis code on the invoice does not match the indication in the operative note or referral letter.

How Pabau keeps E3180 claims complete before submission

UK ENT practices often hold the authorisation letter, the operative note and the insurer invoice in different places. Someone then has to match them up by hand before each claim goes out.

In Pabau, all three sit on the patient record. A typical E3180 workflow runs in five steps:

1. Record the pre-authorisation: before the procedure date, record the insurer’s authorisation number and the approved CCSD codes (E3180 plus any concurrent codes) on the invoice.
2. Attach the operative note: attach the completed operative note to the patient record, next to the referral letter.
3. Create the insurer invoice: add E3180 as a line item, with any pre-authorised co-procedure (e.g. arytenoid adduction) on its own line. Check the procedure date, laterality and consultant details.
4. Keep supporting documents ready: store the laryngoscopy report and referral letter on the patient record. Some insurers request them with the claim, and they are then ready to send.
5. Submit to the insurer: send the claim to Healthcode through Pabau’s streamlined claims management. Then log the insurer’s response and any follow-up on the same record.

The claim reaches the insurer with its authorisation, operative note and codes already matched. When a query comes back, the answer sits on one record instead of three systems.

Billing CCSD codes shouldn’t take longer than the consultation

Keep the operative note, authorisation number and approved CCSD codes on one patient record, then send the insurer claim through Healthcode from the same system.

Book a demo

Conclusion

For CCSD Code E3180, choosing the code is the easy part. Claims come back when the operative note leaves out the Isshiki type, the side or the implant, or when a co-procedure was never authorised.

So build each claim backwards from the insurer’s review. Agree every planned code at pre-authorisation, and use one operative note template that records those details every time. Then check each insurer’s current rules before submission, while you can still fix a missing item.

Book a demo to see how Pabau keeps the authorisation, operative note and insurer invoice for each ENT claim on one patient record.

Continue your research

Billing CCSD codes for other ENT or surgical procedures? Bupa CCSD code schedule provides a reference guide to Bupa-recognised CCSD codes and their current fee levels.

Coding the scope before surgery? CCSD Code E3680 explains endoscopic laryngopharyngoscopy billed as a sole out-patient procedure.

Treating laryngectomy patients too? CCSD Code E4100 covers insertion of a voice prosthesis after total laryngectomy.

Want fewer queried insurer claims? Pabau’s claims management software brings claim submission and follow-up into the same system as the patient record.

Frequently asked questions